Successful treatment by double filtrate plasmapheresis in a pregnant woman with the rare P blood group and a history of multiple early miscarriages

Therapeutic Apheresis and Dialysis

Volumn 10, Issue 6, 2006, Pages 498-503

  Hanafusa, Norio ^a,b   Noiri, Eisei ^b   Yamashita, Takahiro ^b   Kondo, Yasushi ^b   Suzuki, Makoto ^c   Watanabe, Yasuyuki ^b   Kanai, Takao ^b   Miyashita, Emiko ^b   Tsuno, Nelson H ^b   Fujii, Tomoyuki ^b   Kozuma, Shiro ^b   Takahashi, Koki ^b   Taketani, Yuji ^b   Nakao, Akihide ^d   Fujita, Toshiro ^b  

^a University of Tokyo Hospital ^*  (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c Social Insurance Central General Hospital   (Japan)

^d Toshiba General Hospital   (Japan)

Author keywords

Anti PP1Pk antibody; Double filtration plasmapheresis; P blood type; P incompatible pregnancy; Spontaneous abortion

Indexed keywords

ANTIBIOTIC AGENT; BLOOD GROUP ANTIBODY; BLOOD GROUP P ANTIBODY; HEPARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING TENDENCY; BLOOD GROUP P SYSTEM; CASE REPORT; CATHETER INFECTION; CESAREAN SECTION; DOUBLE FILTRATION PLASMAPHERESIS; FEMALE; FETUS GROWTH; GESTATIONAL AGE; GROWTH RETARDATION; HUMAN; PATIENT REFERRAL; PLASMAPHERESIS; PREGNANT WOMAN; PRIORITY JOURNAL; RECURRENT ABORTION; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; FEMALE; HUMANS; P BLOOD-GROUP SYSTEM; PLASMAPHERESIS; PREGNANCY;

EID: 33845644636     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2006.00393.x     Document Type: Article

References (27)

1. Landsteiner K, Levine P. Further observations on individual differences of human blood. Proc Soc Exp Biol Med 1927; 24:941.
2. Naiki M, Fong J, Ledeen R, Marcus DM. Structure of the human erythrocyte blood group P1 glycosphingolipid. Biochemistry 1975;14:4831-7.
3. Naiki M, Marcus DM. Human erythrocyte P and Pk blood group antigens: identification as glycosphingolipids. Biochem Biophys Res Commun 1974;60:1105-11.
4. Taniguchi F, Horie S, Tsukihara S, Nagata N, Nishikawa K, Terakawa N. Successful management of a P-incompatible pregnancy using double filtration plasmapheresis. Gynecol Obstet Invest 2003;56:117-20.
5. Race RR, Sanger R. The P blood groups. In: Blood Groups in Man. Oxford: Blackwell Scientific Publications, 1975;139-77.
6. Sanger R. An association between the P and Jay systems of blood groups. Nature 1955;176:1163-4.
7. Haentjens-Verbeke K, Dufour P, Vinatier D, Tordjeman N, Monnier JC, Manessier L. Anti-Tja alloimmunization (anti-PP1Pk): two consecutive pregnancies of an anti-TJa-carrying patient. Fetal Diagn Ther 1996;11:120-5.
8. Lindstrom K, Von Dem Borne AE, Breimer ME et al. Glycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group, p. women. Evidence for placenta being the primary target for anti-Tja-antibodies. Glycoconj J 1992;9:325-9.
9. Lopez M, Cartron J, Cartron JP et al. Cytotoxicity of anti-PP1Pk antibodies and possible relationship with early abortions of, p. mothers. Clin Immunol Immunopathol 1983;28:296-303.
10. Levine P, Koch EA. The rare human isoagglutinin anti-Tja and habitual abortion. Science 1954;120:239-41.
11. Iseki S, Masaki S, Levine P. A remarkable family with the rare human isoantibody anti-Tja in four siblings: anti Tja and habitual abortion. Nature 1954;173:1193-4.
12. Assali G, Ripamonti M, Bottino S, Borzini P. Relationship between anti-P antibody and habitual abortion in PK1 women. Haematologica 1988;73:401-2.
13. Cantin G, Lyonnais J. Anti-PP1Pk and early abortion. Transfusion 1983;23:350-1.
14. Fernandez-Jimenez MC, Jimenez-Marco MT, Hernandez D, Gonzalez A, Omenaca F, de la Camara C. Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients. Vox Sang 2001;80:117-20.
15. Yoshida H, Ito K, Kusakari T et al. Removal of maternal antibodies from a woman with repeated fetal loss due to P blood group incompatibility. Transfusion 1994;34:702-5.
16. Haentjens-Verbeke K et al. [Isoimmunisation with PP/PR (anti-Tja). A case history, review of the literature]. J Gynecol Obstet Biol Reprod 1993;22:393. (In French)
17. Strowitzki T, Wiedemann R, Heim MU, Brehm G, Roithmeier A. [Pregnancy with an extremely rare P blood group with anti-PP1Pk]. Geburtshilfe Frauenheilkd 1991;51:710-13. (In German)
18. Heim MU, Weidemann R, Brehm G, Versmold H, Mempel W. [Plasmapheresis and/or intermediate high dosage immunoglobulin therapy - effective measures in threatened premature labor and intrauterine hemolysis in anti-PP1Pk (-Tja) ?]. Beitr Infusionsther 1990;26:302-6. (In German)
19. Shechter Y, Timor-Tritsch IE, Lewit N, Sela R, Levene C. Early treatment by plasmapheresis in a woman with multiple abortions and the rare blood group, p. Vox Sang 1987;53:135-8.
20. Aoki K, Fujisawa S, Tanaka H, Mizuno K, Yagami Y. [An early spontaneous abortion case whose cause is inferred as anti-Tja antibody]. Jpn J Fertil Steril 1983;28:649. (In Japanese)
21. Ukita M, Takahashi A, Nunotani T et al. [Plasma exchange in P-incompatible pregnancy-consideration on an unsuccessful case]. Chugoku Shikoku Dist J Jpn Soc Obstet Gynecol 1992;40:457. (In Japanese)
22. Levene C, Sela R, Rudolphson Y, Nathan I, Karplus M, Dvilansky A. Hemolytic disease of the newborn due to anti-PP1 Pk (anti-Tja). Transfusion 1977;17:568-72.
23. Rock JA, Shirey RS, Braine HG, Ness PM, Kickler TS, Niebyl JR. Plasmapheresis for the treatment of repeated early pregnancy wastage associated with anti-P. Obstet Gynecol 1985;66:57S-60S.
24. Yoshida H, Ito K, Emi N, Kanzaki H, Matsuura S. A new therapeutic antibody removal method using antigen-positive red cells. II. Application to a P-incompatible pregnant woman. Vox Sang 1984;47:216-23.
25. Yoshida H, Yoshida Y, Tatsumi K, Asoh T. A new therapeutic antibody removal method using antigen positive red cells. Application to M-incompatible pregnant women. Vox Sang 1982;43:35-44.
26. Theunissen IM, Parer JT. Fluid and electrolytes in pregnancy. Clin Obstet Gynecol 1994;37:3-15.
27. Shemin D. Dialysis in pregnant women with chronic kidney disease. Semin Dial 2003;16:379-83.